1
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T77450 | Vantictumab | OMP-18R5 | |
Vantictumab (OMP-18R5), a fully human IgG2 monoclonal antibody, antagonizes Wnt pathway signaling through binding to FZD1/2/5/7/8 receptors. It is currently under investigation for the treatment of various cancers, inclu... |